About us
Occlutech is a leading specialist provider of minimally invasive cardiac devices, with a mission to improve the quality of life for people with heart conditions.
Since 2003, Occlutech has developed, produced, and commercialized first-class, minimally invasive, cardiac implants for Congenital Heart Disease, Stroke Prevention, and Heart Failure, all with the mission to improve patients’ lives and address unmet medical needs. The devices are sold to hospitals and clinics in over 70 countries and used by physicians in implantation procedures.
Global organization proving customer service
Registered in Switzerland, Occlutech employs around 300 people and has manufacturing and R&D facilities in Germany and Türkiye, a global finance and distribution hub located in Helsingborg, Sweden, as well as clinical operations in Minneapolis, U.S.
Innovation is at the heart of everything we do
+35%
of annual revenue invested in innovation incl. clinical trials (2023).
+200
patents
At Occlutech, we never settle in our aim to provide the best possible quality of products and reliability of our clinical activities. Our commitment to innovation has resulted in a broad and proven product portfolio, based on proprietary technology, which allows for better treatment of patients around the world.
Our customers are our most important source of ideas and inspiration for new products, and our ambition is to be the most responsive industry partner in terms of creating unique solutions for unmet medical needs.
Thousands of patients treated every year
+205,000
devices sold globally
+70
countries
Patient safety and well-being always comes first. Occlutech markets and sells structural heart and interatrial shunt products to treat thousands of patients every year.
